Spasticity: Clinical Trials

2 trials for Spasticity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Terminated 2
Phase 21Terminated 1

Follow Spasticity: new trials by email Literature Review of Spasticity trials Research Report on Spasticity

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
One Year Extension Study To Protocol C2/5/TZ:MS-05
sublingual tizanidine 12 mg - Spasticity, Multiple Sclerosis
Phase 1 / Phase 2TerminatedTeva GTC102008-01-012009-02-19
Botox vs. Baclofen for Upper Limb Spasticity
intramuscular Botox versus oral baclofen - Spasticity
Phase 1TerminatedVanderbilt University82006-02-012012-01-20

Narrower conditions

Muscle Spasticity (2)  ·  Fatigue (1)  ·  Multiple Sclerosis (1)

Broader conditions

Muscle Hypertonia (2)  ·  Muscular Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Neuromuscular Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)  ·  Demyelinating Diseases (1)  ·  Immune System Diseases (1)

Sponsors

Teva GTC (1)  ·  Vanderbilt University (1)

Countries

Israel (1)  ·  United States (1)

Top investigators

Arnon Karni, MD (1)  ·  P. David Charles, MD (1)